NEOS
Neos Therapeutics, Inc.
Set alert
No live quote for NEOS yet.
- Open
- 1.16
- Prev close
- 1.18
- Mkt cap
- 57.22M
- Vol
- 15.01M
- Avg vol
- 7.10M
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.06
- High
- 1.18
- Forward P/E
- -19.17
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.9922
- 200-d avg
- 0.733477
- 1y target
- 1.00
Valuation
P/E -4.4×
FY 2013 5y median -3.5× FY 2019
P/S 1.2×
FY 2013 5y median 10.1× FY 2019
P/B -12.2×
FY 2013 5y median 1.4× FY 2019
P/FCF -6.3×
FY 2013 5y median -4.5× FY 2019
EV/EBITDA -22.0×
FY 2013 5y median -2.2× FY 2019
EV/Sales 1.6×
FY 2013 5y median 11.2× FY 2019
FCF Yield -15.9%
FY 2013 5y median -22.2% FY 2019
Profitability
Gross Margin 61.1%
FY 2013 5y median 46.1% FY 2019
Operating Margin -16.1%
FY 2013 5y median -227.9% FY 2019
Net Margin -26.1%
FY 2013 5y median -264.8% FY 2019
ROE 275.7%
FY 2013 5y median -39.3% FY 2019
ROIC -24.0%
FY 2013 5y median -69.3% FY 2019
ROA -18.6%
FY 2013 5y median -46.4% FY 2019
Growth (YoY)
Revenue 29.3%
FY 2013 FY 2019
Operating Income 76.1%
FY 2013 FY 2019
EPS (diluted) 78.8%
FY 2013 FY 2019
Free Cash Flow 72.1%
FY 2013 FY 2019
Financial Health
Current Ratio 1.1×
FY 2013 5y median 2.2× FY 2019
Quick Ratio 0.9×
FY 2013 5y median 1.8× FY 2019
Debt / Equity -7.3×
FY 2013 5y median 0.4× FY 2019
Net Debt / EBITDA -6.0×
FY 2013 5y median -0.5× FY 2019
Interest Coverage -1.3×
FY 2013 5y median -5.7× FY 2019
Dividends
Dividend Yield 0.0%
FY 2013 5y median 0.0% FY 2019
Payout Ratio 0.0%
FY 2013 5y median 0.0% FY 2019
Annual · latest fiscal year ends 2019-12-31